We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
(+18%)
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$177M |
| 2 |
Lowe's Companies
LOW
|
+$108M |
| 3 |
STJ
St Jude Medical
STJ
|
+$95.4M |
| 4 |
Newell Brands
NWL
|
+$88.6M |
| 5 |
Constellation Brands
STZ
|
+$87.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$136M |
| 2 |
UnitedHealth
UNH
|
+$99.3M |
| 3 |
PayPal
PYPL
|
+$85.4M |
| 4 |
Starbucks
SBUX
|
+$78.1M |
| 5 |
Cigna
CI
|
+$64.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.63% |
| 2 | Consumer Discretionary | 12.48% |
| 3 | Communication Services | 12.09% |
| 4 | Technology | 9.72% |
| 5 | Industrials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIRM
451
DELISTED
Air Methods Corp
AIRM
| $4.02M | 0.03% |
127,638
+84,219
| +194% | +$2.87M |
|
452
Usana Health Sciences
USNA
$394M
| $4.02M | 0.03% |
+58,080
| New | +$3.83M |
|
|
VLRS
453
Controladora Vuela Compania de Aviacion
VLRS
$876M
| $4.01M | 0.03% |
+230,486
| New | +$4.18M |
|
454
Dover
DOV
$27.2B
| $4M | 0.03% |
67,306
+14,988
| +29% | +$867K |
|
|
AXON
455
Axon Enterprise
AXON
$40.5B
| $3.99M | 0.03% |
+139,505
| New | +$3.87M |
|
456
Visteon
VC
$2.77B
| $3.99M | 0.03% |
+55,674
| New | +$3.89M |
|
|
JCP
457
DELISTED
J.C. Penney Company, Inc.
JCP
| $3.99M | 0.03% |
+432,432
| New | +$4.12M |
|
|
OCLR
458
DELISTED
Oclaro Inc.
OCLR
| $3.97M | 0.03% |
+464,576
| New | +$3.23M |
|
459
LKQ Corp
LKQ
$6.58B
| $3.93M | 0.03% |
+110,887
| New | +$3.84M |
|
460
IQVIA
IQV
$34.7B
| $3.91M | 0.03% |
48,213
-137,184
| -74% | -$10.4M |
|
|
STRZA
461
DELISTED
Starz - Series A
STRZA
| $3.9M | 0.03% |
125,028
-94,535
| -43% | -$2.91M |
|
462
Regeneron Pharmaceuticals
REGN
$68.8B
| $3.88M | 0.03% |
9,639
-11,256
| -54% | -$4.52M |
|
463
NRG Energy
NRG
$29.8B
| $3.87M | 0.03% |
345,409
+57,347
| +20% | +$748K |
|
|
MDR
464
DELISTED
McDermott International
MDR
| $3.86M | 0.03% |
256,777
+153,839
| +149% | +$2.3M |
|
|
PRMW
465
DELISTED
Primo Water Corporation
PRMW
| $3.81M | 0.03% |
267,705
-208,227
| -44% | -$3.19M |
|
|
FOE
466
DELISTED
Ferro Corporation
FOE
| $3.81M | 0.03% |
276,205
-85,542
| -24% | -$1.13M |
|
467
Steris
STE
$20.9B
| $3.79M | 0.03% |
51,853
-128,420
| -71% | -$9.07M |
|
468
GE Aerospace
GE
$367B
| $3.79M | 0.03% |
26,693
-54,380
| -67% | -$8.11M |
|
|
BATS
469
DELISTED
Bats Global Markets, Inc.
BATS
| $3.76M | 0.03% |
124,729
-9,698
| -7% | -$249K |
|
470
Baidu
BIDU
$35.8B
| $3.72M | 0.03% |
20,426
+13,073
| +178% | +$2.26M |
|
471
Strategy Inc
MSTR
$33.5B
| $3.71M | 0.03% |
221,820
-534,960
| -71% | -$9.2M |
|
472
Ryanair
RYAAY
$29.5B
| $3.69M | 0.03% |
+123,110
| New | +$3.57M |
|
473
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
| $3.69M | 0.03% |
104,568
-45,508
| -30% | -$1.56M |
|
474
VEON
VEON
$3.53B
| $3.66M | 0.03% |
+42,080
| New | +$4.23M |
|
475
Take-Two Interactive
TTWO
$43B
| $3.66M | 0.03% |
81,126
-271,443
| -77% | -$11.4M |
|
Similar funds
Marshall Wace's Q3 2016 Portfolio in Review
As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.
- Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
- Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
- Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
- Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
- Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.
Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.